218 related articles for article (PubMed ID: 30259116)
1. Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus.
de Vries TI; Kappelle LJ; van der Graaf Y; de Valk HW; de Borst GJ; Nathoe HM; Visseren FLJ; Westerink J;
Acta Diabetol; 2019 Apr; 56(4):431-440. PubMed ID: 30259116
[TBL] [Abstract][Full Text] [Related]
2. Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in type 2 diabetes.
de Vries TI; de Valk HW; van der Graaf Y; de Borst GJ; Cramer MJM; Jaap Kappelle L; Visseren FLJ; Westerink J;
Diabetes Res Clin Pract; 2019 Nov; 157():107880. PubMed ID: 31628967
[TBL] [Abstract][Full Text] [Related]
3. Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study.
Jun JE; Jee JH; Bae JC; Jin SM; Hur KY; Lee MK; Kim TH; Kim SW; Kim JH
Thyroid; 2017 Jan; 27(1):29-38. PubMed ID: 27809684
[TBL] [Abstract][Full Text] [Related]
4. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.
Xu Y; Derakhshan A; Hysaj O; Wildisen L; Ittermann T; Pingitore A; Abolhassani N; Medici M; Kiemeney LALM; Riksen NP; Dullaart RPF; Trompet S; Dörr M; Brown SJ; Schmidt B; Führer-Sakel D; Vanderpump MPJ; Muendlein A; Drexel H; Fink HA; Ikram MK; Kavousi M; Rhee CM; Bensenor IM; Azizi F; Hankey GJ; Iacoviello M; Imaizumi M; Ceresini G; Ferrucci L; Sgarbi JA; Bauer DC; Wareham N; Boelaert K; Bakker SJL; Jukema JW; Vaes B; Iervasi G; Yeap BB; Westendorp RGJ; Korevaar TIM; Völzke H; Razvi S; Gussekloo J; Walsh JP; Cappola AR; Rodondi N; Peeters RP; Chaker L;
Lancet Diabetes Endocrinol; 2023 Oct; 11(10):743-754. PubMed ID: 37696273
[TBL] [Abstract][Full Text] [Related]
5. Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus.
Triolo M; Kwakernaak AJ; Perton FG; de Vries R; Dallinga-Thie GM; Dullaart RP
Atherosclerosis; 2013 Jun; 228(2):466-71. PubMed ID: 23591416
[TBL] [Abstract][Full Text] [Related]
6. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects.
Jun JE; Jin SM; Jee JH; Bae JC; Hur KY; Lee MK; Kim SW; Kim JH
Endocrine; 2017 Mar; 55(3):944-953. PubMed ID: 28042645
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroxinemia is positively associated with prevalent and incident type 2 diabetes mellitus in two population-based samples from Northeast Germany and Denmark.
Ittermann T; Schipf S; Dörr M; Thuesen BH; Jørgensen T; Völzke H; Markus MRP
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):173-179. PubMed ID: 29239740
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity.
Langén VL; Niiranen TJ; Puukka P; Lehtonen AO; Hernesniemi JA; Sundvall J; Salomaa V; Jula AM
Clin Endocrinol (Oxf); 2018 Jan; 88(1):105-113. PubMed ID: 28862752
[TBL] [Abstract][Full Text] [Related]
9. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.
Thayakaran R; Adderley NJ; Sainsbury C; Torlinska B; Boelaert K; Šumilo D; Price M; Thomas GN; Toulis KA; Nirantharakumar K
BMJ; 2019 Sep; 366():l4892. PubMed ID: 31481394
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.
Aubert CE; Floriani C; Bauer DC; da Costa BR; Segna D; Blum MR; Collet TH; Fink HA; Cappola AR; Syrogiannouli L; Peeters RP; Åsvold BO; den Elzen WPJ; Luben RN; Bremner AP; Gogakos A; Eastell R; Kearney PM; Hoff M; Le Blanc E; Ceresini G; Rivadeneira F; Uitterlinden AG; Khaw KT; Langhammer A; Stott DJ; Westendorp RGJ; Ferrucci L; Williams GR; Gussekloo J; Walsh JP; Aujesky D; Rodondi N;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2719-2728. PubMed ID: 28482002
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects.
Gu Y; Li H; Bao X; Zhang Q; Liu L; Meng G; Wu H; Du H; Shi H; Xia Y; Su Q; Fang L; Yu F; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Guo Q; Chang H; Wang G; Huang G; Song K; Niu K
J Clin Endocrinol Metab; 2017 Feb; 102(2):434-442. PubMed ID: 27906594
[TBL] [Abstract][Full Text] [Related]
12. Low normal thyroid function as a determinant of increased large very low density lipoprotein particles.
van Tienhoven-Wind L; Dullaart RP
Clin Biochem; 2015 May; 48(7-8):489-94. PubMed ID: 25666190
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function and life expectancy with and without noncommunicable diseases: A population-based study.
Bano A; Chaker L; Mattace-Raso FUS; Terzikhan N; Kavousi M; Ikram MA; Peeters RP; Franco OH
PLoS Med; 2019 Oct; 16(10):e1002957. PubMed ID: 31652264
[TBL] [Abstract][Full Text] [Related]
14. Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States.
Inoue K; Tsujimoto T; Saito J; Sugiyama T
Thyroid; 2016 Oct; 26(10):1457-1465. PubMed ID: 27539006
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years.
Leader A; Ayzenfeld RH; Lishner M; Cohen E; Segev D; Hermoni D
J Clin Endocrinol Metab; 2014 Aug; 99(8):2665-73. PubMed ID: 24885627
[TBL] [Abstract][Full Text] [Related]
16. Higher Plasma ApoE Levels are Associated with Low-Normal Thyroid Function: Studies in Diabetic and Nondiabetic Subjects.
van Tienhoven-Wind LJ; Dallinga-Thie GM; Dullaart RP
Horm Metab Res; 2016 Jul; 48(7):462-7. PubMed ID: 26916531
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Dysfunction and Anemia: A Prospective Cohort Study and a Systematic Review.
Floriani C; Feller M; Aubert CE; M'Rabet-Bensalah K; Collet TH; den Elzen WPJ; Bauer DC; Angelillo-Scherrer A; Aujesky D; Rodondi N
Thyroid; 2018 May; 28(5):575-582. PubMed ID: 29631476
[TBL] [Abstract][Full Text] [Related]
18. Reference interval for thyrotropin in a ultrasonography screened Korean population.
Kim M; Kim TY; Kim SH; Lee Y; Park SY; Kim HD; Kwon H; Choi YM; Jang EK; Jeon MJ; Kim WG; Shong YK; Kim WB
Korean J Intern Med; 2015 May; 30(3):335-44. PubMed ID: 25995664
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
20. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
Ye X; Kong W; Zafar MI; Chen LL
Cardiovasc Diabetol; 2019 Apr; 18(1):48. PubMed ID: 30987625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
